Observational studyThe Journal of infectious diseases2022

Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.

Neil R Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.